AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsed Sarcomas

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas NCT05210374Phase 11 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma NCT06892678Phase 1, Phase 21 site๐Ÿ“ The Bronx Montefiore Medical Center ยท Tests: DFMO Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) NCT06299553n/a1 site๐Ÿ“ Milan Incyte Biosciences Italy S.r.l FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites๐Ÿ“ Brisbane๐Ÿ“ Camperdown๐Ÿ“ Clayton University of Birmingham ยท Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. NCT06514313Phase 21 site๐Ÿ“ Guangzhou Yizhuo Zhang ยท Tests: Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine, Temozolomide+Irinotecan+Vincristine ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas NCT05830123Phase 211 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Guangzhou Hansoh BioMedical R&D Company ยท Tests: HS-20093 Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma NCT07144254Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Houston Emory University ยท Tests: Tegavivint, Gemcitabine Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites๐Ÿ“ Aarhus๐Ÿ“ Aarhus๐Ÿ“ Copenhagen Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Experimental group : Cabometyx ยฎ 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (iโ€ฆ Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 Actinium Therapy for Late-stage Aggressive Sarcomas NCT07156565Phase 16 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester๐Ÿ“ New York Ratio Therapeutics, Inc. ยท Tests: [Ac 225]RTX-2358, [Cu64]LNTH-1363S Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL NCT06287398Phase 21 site๐Ÿ“ Melbourne Australasian Leukaemia and Lymphoma Group ยท Tests: Epcoritamab Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms NCT04797767Phase 1, Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Cladribine, Cytarabine, Mitoxantrone, Recombinant Granulocyte Colony-Stimulating Factor, Venetoclax TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites๐Ÿ“ Camperdown๐Ÿ“ Malvern๐Ÿ“ Nedlands Treeline Biosciences, Inc. ยท Tests: TLN-499, Venetoclax cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites๐Ÿ“ Duarte๐Ÿ“ Miami๐Ÿ“ Gainesville Adela, Inc Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas NCT04621201n/a10 sites๐Ÿ“ Torino๐Ÿ“ Bologna๐Ÿ“ Bologna Azienda Ospedaliera Ospedale Infantile Regina Margherita Saโ€ฆ ยท Tests: observation and biopsy Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL NCT07255963Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Pirtobrutinib, Lisaftoclax, Rituximab Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma NCT07249905Phase 1, Phase 26 sites๐Ÿ“ Richmond๐Ÿ“ Nedlands๐Ÿ“ Haifa ModeX Therapeutics, An OPKO Health Company ยท Tests: MDX2003 Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Miltenyi CliniMACS Prodigy ยฎ system, Zoledronic acid Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma NCT05400603Phase 11 site๐Ÿ“ Atlanta Emory University ยท Tests: Ex Vivo Expanded Allogeneic ฮณฮด T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Losartan + Sunitinib in Treatment of Osteosarcoma NCT03900793Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Losartan, Sunitinib 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites๐Ÿ“ Dothan๐Ÿ“ Grand Rapids๐Ÿ“ Omaha Radiopharm Theranostics, Ltd ยท Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma NCT05734066Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C. Jazz Pharmaceuticals ยท Tests: Lurbinectedin Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas NCT06465199Phase 1, Phase 214 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Hartford Milton S. Hershey Medical Center ยท Tests: Eflornithine (DFMO), AMXT 1501 Dicaprate Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma NCT06830031Phase 11 site๐Ÿ“ Tianjin Shanghai Exuma Biotechnology Ltd. ยท Tests: C402-CD19-CAR
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy